Mindy and Ryan are joined by friends and colleagues, Karen Baldry & Chris Savage to debate why new medicines matter. With novel therapies addressing complex disease states that come with significant price points, the panel discusses why the launch of a new product is critical for life science organizations. The panel discusses what it means that an increasing number of launches fall into specialty markets and how launch practices are shifting to reflect new dynamics and complexity.
18 January 2018
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Mindy McGrath
Are you ready for the Inflation Reduction Act? Assess your readiness and adapt strategies to thrive amid regulatory changes in the healthcare...
Read moreDuring Fierce Life Science’s MASS East, Medical Affairs leaders gathered to address current challenges and share...
Listen nowAs competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and...
Listen now